�Agendia, a world leader in molecular cancer diagnostics, announced the launch of TargetPrint(R), a new diagnostic test that
allows physicians to quantitatively determine the gene expression levels of
the oestrogen receptor (ER), progesterone sensory receptor (PR) and Human Epidermal
growth broker Receptor 2 (HER2) in breast cancer tumor biopsies. The
accurate measurement of these receptors is of paramount importance in
planning treatment of breast cancer patients after surgery and assists
physicians and patients in fashioning informed treatment decisions. TargetPrint
runs on Agendia's novel High Density Chip, which received market place clearance
last month (August 2008) from the U.S. Food and Drug Administration (FDA).
"Currently available targeted therapies, such as hormone treatments,
john have a huge shock on the survival and quality of life of a important
number of breast cancer patients," aforesaid Bernhard Sixt, Ph.D., prexy and
top dog executive military officer of Agendia. "TargetPrint will play a key persona in
shaping which patients are to the highest degree likely to benefit from these treatments."
"The test's results break a accurate molecular readout of presage
parameters for breast cancer and provide physicians and patients with
reliable guidance on the most suitable treatment for each single
patient," aforementioned Richard A. Bender, MD, FACP, top dog medical policeman of
Agendia. "In the near future, it is our project to tote up information on a wider
range of drug targets to TargetPrint and clinically validate these with key
customers."
Agendia will acquaint clinical data on TargetPrint at The 2008 Breast
Cancer Symposium which is co-sponsored by the American Society of Clinical
Oncology (ASCO) and will be held in Washington, DC from September 5-7,
2008. TargetPrint is processed at Agendia's Clinical Laboratory Improvement
Amendments (CLIA) certified and the College of American Pathology (CAP)
accredited laboratory.
About Agendia
Agendia is a world leader in molecular cancer diagnostics. The company
markets quatern products based on its breakthrough platform for tumour gene
expression profiling and has several new symptomatic tests below
development. Agendia was the first fellowship to welcome FDA clearance for a
breast cancer test, MammaPrint(R), that predicts the risk of exposure of breast cancer
return. In addition, the company collaborates with pharma companies to
make grow highly effective personalized drugs in the area of oncology.
Agendia is based in Huntington Beach, California, and in Amsterdam, The
Netherlands. For more information on Agendia, please visit http://www.agendia.com.
Agendia
http://www.agendia.com
More info
Sunday, 7 September 2008
Friday, 29 August 2008
Mylan Signs Deal With Indian Firm To Develop 22 Oral Contraceptives
�Mylan on Wednesday announced a deal with Indian drug divine Famy Care to build up and sell 22 generic oral prophylactic device products, the Pittsburgh Tribune-Review reports (Stouffer, Pittsburgh Tribune-Review, 8/7). Mylan plans to seek FDA approval for the products over the next few months and hopes to begin marketing them in 2010. Under the price of the deal, Mylan can sell other contraceptives in other markets, including Australia and Japan. Mylan did not disclose fiscal terms of the dispense (AP/Yahoo! News, 8/6).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free overhaul of the National Partnership for Women & Families, published by The Advisory Board Company.
� 2008 The Advisory Board Company. All rights reserved.
More info
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free overhaul of the National Partnership for Women & Families, published by The Advisory Board Company.
� 2008 The Advisory Board Company. All rights reserved.
More info
Tuesday, 19 August 2008
Download Phil Miller mp3
Artist: Phil Miller: mp3 download Genre(s): Jazz Discography: Digging In Year: 2000 Tracks: 7 Guitarist Phil Miller has long been a speed in British progressive music. In 1971, he helped install the band Matching Mole with drummer/vocalist Robert Wyatt of Soft Machine. Matching Mole broke up later on cathartic two LPs, Matching Mole and Short Red Record. Miller then formed Hatfield and the North with Dave Stewart, Richard Sinclair (Van), and Pip Pyle (Gong). Hatfield recorded 2 LPs for Virgin in the mid-'70s: Hatfield and the North and The Rotter's Club. Hatfield evolved into National Health, which recorded National Health, Of Queues and Cures, and D.S. Al Coda. All 3 LPs possess been reissued on a two-CD bound, National Health Complete (East Side Digital). Since the detachment of National Health, Miller has worked on solo projects and with his band, In Cahoots. He has released deuce-ace solo efforts: Press press cutting Both Ways (Cuneiform), Split Seconds (Heedless), and Dig In (Cuneiform). |
Saturday, 9 August 2008
JC Mazter and Noizzer
Artist: JC Mazter and Noizzer
Genre(s):
House
Discography:
JC Mazter EP 2-(RVC002) WEB
Year: 2007
Tracks: 2
 
Tuesday, 1 July 2008
Stars come out for Elton John's ball
London (ANI): Stars came out in full force to adorn one of the most exclusive events on the social calendar of the celebs – Sir Elton John's White Tie And Tiara ball. Liz Hurley, Gordon Ramsay and former US President Bill Clinton were among those present at the do, reports the Daily Express. Hurley was joined by husband Arun Nayer, while Ramsay took wife Tana to the 3,000pounds-a-head charity bash at Sir Elton's Berkshire estate. Sir Michael Caine, Mischa Barton and couple Will Smith and Jada Pinkett Smith also attended the party, along with Graham Norton, Elle MacPherson, Lulu, and Kelly Osbourne and boyfriend Luke Worrell. Ex-Wimbledon Champion Roger Federer was also at the 'beach party'-themed event, which included entertainment from Beach Boys star Brian Wilson.
.adlinks{font-family:arial;font-size:12px;color:#ffffff !important;line-height:19px;background-color: #F47321;}
.adlinks{font-family:arial;font-size:12px;color:#ffffff !important;line-height:19px;background-color: #F47321;}
Monday, 23 June 2008
George's track is on to a winner
JUST over a week after GEORGE SAMPSON’s Britain’s Got
Talent victory, MINT ROYALE have landed No1 for their remix of Singin’
In The Rain.
But before you start imagining NEIL CLAXTON, the Manchester muso
behind the band, spraying champagne everywhere, think again.
SIMON COWELL holds the publishing rights to the song and most of the
wedge earned will filter its way back to SonyBMG.
In the album charts the Modfather PAUL WELLER gets a well deserved No1
for his double CD 22 Dreams.
Talent victory, MINT ROYALE have landed No1 for their remix of Singin’
In The Rain.
But before you start imagining NEIL CLAXTON, the Manchester muso
behind the band, spraying champagne everywhere, think again.
SIMON COWELL holds the publishing rights to the song and most of the
wedge earned will filter its way back to SonyBMG.
In the album charts the Modfather PAUL WELLER gets a well deserved No1
for his double CD 22 Dreams.
Monday, 16 June 2008
Suga Free and Mausberg present
Artist: Suga Free and Mausberg present
Genre(s):
funk
Discography:
The Konnected Project
Year:
Tracks: 15
 
Subscribe to:
Comments (Atom)

